Glaucoma
📧 Sign up to get email alerts when something new happens for Glaucoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-09-26Clinical Trial Update: A Dose Evaluation Study of the Effect of Plug Placement on the Efficacy and Safety of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma [Phase 2]
Phase 2 dose-evaluation trial assessing the effect of punctal plug placement on the efficacy and safety of the Latanoprost punctal plug deli…
-
CLINICAL_TRIALS trial_result · 2013-09-19Clinical Trial Update: A Study of Different Formulations of the L-PPDS in Subjects With OH or OAG [Phase 2]
A completed Phase 2 clinical trial evaluating different formulations of L-PPDS in subjects with glaucoma or ocular hypertension.
-
CLINICAL_TRIALS trial_result · 2013-09-19Clinical Trial Update: Safety and Efficacy of Triple Combination Therapy in Patients With Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 trial results evaluating the safety and efficacy of a triple combination therapy in patients with glaucoma or ocular hypertension.
-
CLINICAL_TRIALS trial_result · 2013-09-19Clinical Trial Update: A Safety Study of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open Angle Glaucoma [Phase 2]
A Phase 2 safety study evaluating the Latanoprost Punctal Plug Delivery System (L-PPDS) in subjects with ocular hypertension or open-angle g…
-
CLINICAL_TRIALS trial_result · 2013-09-19Clinical Trial Update: Study of the Effects of Artificial Tears on the Response to the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma [Phase 2]
Phase 2 study evaluating whether artificial tears affect the response to a latanoprost punctal plug delivery system in adults with glaucoma …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2013-09-17Clinical Trial Update: A Phase 2 Study of the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma [Phase 2]
A Phase 2 trial evaluating a latanoprost punctal plug delivery system for ocular hypertension or open-angle glaucoma was withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-09-10Clinical Trial Update: Imaging of Trabeculectomy Blebs Using the Spectral Domain Optical Coherence Tomography
A completed clinical trial from Technische Universität Dresden evaluated imaging of trabeculectomy filtering blebs using spectral-domain opt…
-
CLINICAL_TRIALS trial_result · 2013-09-09Clinical Trial Update: SENSIMED Triggerfish Safety and Tolerability [NA]
A clinical trial evaluating the safety and tolerability of the SENSIMED Triggerfish device for glaucoma has completed. Results were posted o…
-
FDA approval · 2013-08-28FDA Approved: TAFLUPROST OPHTHALMIC — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for Tafluprost Ophthalmic submitted by Prasco Laboratories. Tafluprost ophthalmic is used to low…
-
CLINICAL_TRIALS trial_result · 2013-08-19Clinical Trial Update: Trabeculectomy Versus Canaloplasty [NA]
This completed clinical trial compares trabeculectomy versus canaloplasty for glaucoma. The snippet does not include trial outcomes.
-
CLINICAL_TRIALS trial_result · 2013-07-26Clinical Trial Update: Ranibizumab in Preventing Failure of Ahmed Valve Glaucoma Surgery [NA]
Clinical trial update about using ranibizumab to prevent failure of Ahmed valve glaucoma surgery; study terminated with results posted in 20…
-
FDA approval · 2013-07-19FDA Approved: OSMITROL — Supplemental Application (Baxter Healthcare Company)
The FDA approved a supplemental application for Osmitol (mannitol) from Baxter Healthcare Company, resulting in updated labeling to reflect …
-
CLINICAL_TRIALS withdrawal · 2013-07-18Clinical Trial Update: Safety and Efficacy of Triple Combination Therapy With Dorzolamide Hydrochloride / Brimonidine Tartrate / Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension [Phase 3]
A Phase 3 trial evaluating the safety and efficacy of a triple combination dorzolamide hydrochloride/brimonidine tartrate/timolol ophthalmic…
-
CLINICAL_TRIALS trial_result · 2013-07-17Clinical Trial Update: Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma [Phase 2]
This document reports the completion of a Phase 2 multiple-dose escalation study of AMA0076 in patients with glaucoma or ocular hypertension…
-
CLINICAL_TRIALS trial_result · 2013-07-08Clinical Trial Update: Safety and Efficacy of Changing to DuoTrav in Patients Uncontrolled on Timolol [Phase 4]
Phase 4 trial evaluating safety and efficacy of switching from timolol to DuoTrav (dorzolamide/timolol fixed-dose combination) in glaucoma p…
-
CLINICAL_TRIALS trial_result · 2013-06-28Clinical Trial Update: Prospective Comparative Clinical Study to Investigate the Use of the NON CONTACT TONO/PACHYMETER NT-530P [NA]
A prospective comparative clinical study evaluating the NON CONTACT TONO/PACHYMETER NT-530P for intraocular pressure measurement has complet…
-
CLINICAL_TRIALS trial_result · 2013-06-25Clinical Trial Update: Macular Ganglion Cell Analysis (GCA) of the Cirrus HD-OCT in Glaucoma
A completed clinical trial evaluating macular ganglion cell analysis (GCA) using Cirrus HD-OCT in glaucoma patients.
-
CLINICAL_TRIALS research · 2013-06-17Clinical Trial Update: Living Successfully With Chronic Eye Diseases [NA]
A clinical trial update from the Singapore Eye Research Institute about living with chronic eye diseases, listing conditions such as diabeti…
-
FDA approval · 2013-06-05FDA Approved: ALPHAGAN P — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for Alphagan P (brimonidine tartrate) submitted by Allergan, Inc.
-
CLINICAL_TRIALS trial_result · 2013-04-26Clinical Trial Update: AZARGA Transition Study in Taiwan for Patients With Uncontrolled Intraocular Pressure [Phase 4]
The AZARGA Transition Study conducted in Taiwan for patients with uncontrolled intraocular pressure in glaucoma has completed Phase 4 with r…
-
CLINICAL_TRIALS trial_result · 2013-04-24Clinical Trial Update: Effects of Selective Laser Trabeculoplasty
A terminated clinical trial assessed the effects of selective laser trabeculoplasty for glaucoma.
-
FDA approval · 2013-04-19FDA Approved: SIMBRINZA — Original Application (Alcon Laboratories, Inc.)
The FDA approved SIMBRINZA (brinzolamide/brimonidine tartrate) through an original NDA by Alcon Laboratories, establishing it as a fixed-dos…
-
CLINICAL_TRIALS trial_result · 2013-04-15Clinical Trial Update: Comparing Eye Pressure Using Maximal Tolerated Local Therapy or Systemic Acetazolamide
A University of Cologne trial compared maximal tolerated local therapy with systemic acetazolamide for lowering elevated intraocular pressur…
-
CLINICAL_TRIALS research · 2013-04-15Clinical Trial Update: Trabeculectomy Versus Canaloplasty to Treat Glaucoma [NA]
This clinical trial update discusses a study comparing trabeculectomy and canaloplasty for glaucoma. The trial status is not specified.
-
CLINICAL_TRIALS trial_result · 2013-03-22Clinical Trial Update: Circadian Ocular Perfusion Pressure and Ocular Blood Flow [Phase 4]
Phase 4 clinical trial update from Alcon Research evaluating circadian ocular perfusion pressure and ocular blood flow in glaucoma. Results …